GLP-1 Bridge is Here. How Latent Helps
Today, Medicare opens the GLP-1 Bridge program. That means millions of people could now be eligible for a medicine that used to run more than $1,000 a month could now cost about $50.
That's a real win for the patients who need it. It also means a new wave of volume heading toward pharmacy teams who are already carrying an ever-mounting workload.
Our partners saw this coming weeks ago, and reached out. Latent's enterprise pharmacy intelligence platform is already helping them handle today's patient load…but they knew the Bridge was a different kind of challenge, one with real consequences for their teams.
So we built a solution for the GLP-1 Bridge requirements specifically, ready in time for today. And alongside a small group of early adopters who wanted to go further, we also started building new autonomous, agentic solutions to help.
This working paper walks through what the GLP-1 Bridge is, what it means for pharmacy teams, and what we're building to help our partners meet the wave that's coming.
